Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Repurposing Candidate Drugs to Prevent SARS-CoV-2: A PharmLines Test-Negative Case-Control Study.

Pharmaceuticals (Basel, Switzerland)·2026

Same author

Kidney Transplant Recipients Develop Nasal Mucosal Antibodies to SARS-CoV-2 With ACE2-Inhibiting Activity Following mRNA Vaccination.

Transplant infectious disease : an official journal of the Transplantation Society·2026

Same author

Influenza vaccine-specific CD4<sup>+</sup> T cell responses are impaired in older adults.

NPJ vaccines·2026

Same author

COVID-19 boosters restore virus-specific immune responses in kidney transplant recipients unresponsive to primary vaccination.

Npj viruses·2026

Same author

Activation phenotypes defined by the coordinated expression of activation markers discriminate TCR-mediated and bystander T cell responses.

iScience·2026

Same author

Proteomic Signatures Over Age Reveal Significant Changes From Infancy Till Late Adulthood.

Advanced biology·2026

Search research articles

Related Experiment Video

Updated: May 28, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Association between IL28B polymorphisms and first-phase viral load decrease in chronic hepatitis C virus-infected

Joop E Arends¹, Justin H Fransen, Andy I M Hoepelman

¹Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Heidelberglaan 100, PO Box 85500, 3508 GA Utrecht, The Netherlands. j.e.arends@umcutrecht.nl

International Journal of Antimicrobial Agents

|October 7, 2011

Summary

This summary is machine-generated.

Interleukin-28B (IL28B) gene variations impact hepatitis C virus (HCV) treatment outcomes. Patients with the CC genotype showed better viral load reduction and treatment efficiency, highlighting the role of host genetics in HCV clearance.

More Related Videos

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Published on: October 1, 2015

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Experiment Videos

Last Updated: May 28, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Published on: October 1, 2015

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Area of Science:

Genetics
Virology
Immunology

Background:

Host genetic factors, specifically polymorphisms in the IL28B region, are increasingly recognized for their influence on treatment outcomes for chronic hepatitis C virus (HCV) infection.
Previous research suggests a link between IL28B variants and the response to antiviral therapies for HCV.

Purpose of the Study:

To investigate the association between the IL28B rs12979860 polymorphism and the first-phase viral load decrease in patients with chronic HCV infection.
To evaluate the treatment efficiency factor (ɛ) in relation to different IL28B genotypes during HCV treatment.

Main Methods:

Genotyping of the IL28B rs12979860 polymorphism in a cohort of chronic HCV-infected patients.
Quantification of viral load to assess the first-phase viral load decrease.
Calculation of the treatment efficiency factor (ɛ) based on viral kinetics.

Main Results:

A significant association was observed between the IL28B rs12979860 polymorphism and the first-phase viral load decrease in chronic HCV patients.
Patients with the CC genotype exhibited a higher treatment efficiency factor (ɛ) compared to those with CT and TT genotypes.
These findings indicate that host genetic makeup influences the early response to HCV treatment.

Conclusions:

The IL28B rs12979860 polymorphism is a significant predictor of early treatment response in chronic hepatitis C virus infection.
Host genetic factors, exemplified by IL28B variations, play a crucial role in the efficacy of HCV treatment and viral clearance.
Understanding these host response mechanisms can contribute to personalized treatment strategies for HCV.